NCT00408772View on ClinicalTrials.gov

Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal Cancer

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Colorectal CancerMetastatic Cancer
Interventions
BIOLOGICAL

bevacizumab

DRUG

capecitabine

DRUG

oxaliplatin

PROCEDURE

conventional surgery

PROCEDURE

neoadjuvant therapy

PROCEDURE

radiofrequency ablation

Trial Locations (1)

95817

University of California Davis Cancer Center, Sacramento

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

University of California, Davis

OTHER